Clinical Trials
9
Active:0
Completed:7
Trial Phases
4 Phases
Phase 2:1
Phase 3:3
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 3
3 (37.5%)Not Applicable
2 (25.0%)Phase 4
2 (25.0%)Phase 2
1 (12.5%)A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening
- Conditions
- Prostate Cancer
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- TSH Biopharm Corporation Limited
- Target Recruit Count
- 200
- Registration Number
- NCT05180305
- Locations
- 🇨🇳
Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
Propafenone in the Treatment of Atrial Fibrillation
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- TSH Biopharm Corporation Limited
- Target Recruit Count
- 71
- Registration Number
- NCT03674658
- Locations
- 🇨🇳
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- TSH Biopharm Corporation Limited
- Target Recruit Count
- 20
- Registration Number
- NCT03401502
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Zhongzheng Dist, Taiwan
Corever in the Treatment of Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- Drug: Corever
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2016-11-04
- Lead Sponsor
- TSH Biopharm Corporation Limited
- Target Recruit Count
- 134
- Registration Number
- NCT02432937
- Locations
- 🇨🇳
Hualien Tzu Chi Hospital, Hualien, Taiwan
🇨🇳Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Extended-Release RANCAD in the Patients With Stable Angina Pectoris
Phase 3
Completed
- Conditions
- Stable Angina Pectoris
- Interventions
- Drug: RANCAD
- First Posted Date
- 2014-11-19
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- TSH Biopharm Corporation Limited
- Target Recruit Count
- 75
- Registration Number
- NCT02294942
- Locations
- 🇨🇳
Far Eastern Memorial Hospital, New Taipei city, Taiwan
🇨🇳Mackay Memorial Hospital, Taipei City, Taiwan
🇨🇳Shin Kong WuHoSu Memorial Hospital, Taipei, Taiwan
- Prev
- 1
- 2
- Next
News
No news found